Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapy.
Lee WH, Shen YR, Huang BC, Ho KW, Chen CK, Wu HH, Hsieh YH, Lu YC, Cheng YA, Lee YC, Hong ST, Liao TY, Chang CC, Liu LY, Yang MC, Chang TH, Cheng TL, Chen YY, Lin WW.
Lee WH, et al. Among authors: lin ww.
Int J Biol Macromol. 2025 May;309(Pt 4):143176. doi: 10.1016/j.ijbiomac.2025.143176. Epub 2025 Apr 15.
Int J Biol Macromol. 2025.
PMID: 40246093